Answers are grounded in this paper and cite their sources.
Laser-assisted indocyanine green angiography is not cost-effective as a preventative measure for flap necrosis if used indiscriminately on all patients undergoing prosthesis-based breast reconstructions, but it is cost-effective for high-risk patients, such as smokers, obese patients, and patients with large breasts.
No takes yet. Share an insight, caveat, or question.
Kanuri et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: